Holen Sie sich die Stockscreener-App
2.16
7.46%
0.15
Handel nachbörslich:
2.18
0.02
+0.93%
Schlusskurs vom Vortag:
$2.01
Offen:
$2.03
24-Stunden-Volumen:
948.20K
Relative Volume:
0.53
Marktkapitalisierung:
$143.70M
Einnahmen:
$488.00K
Nettoeinkommen (Verlust:
$-41.44M
KGV:
-2.3226
EPS:
-0.93
Netto-Cashflow:
$-31.47M
1W Leistung:
+3.85%
1M Leistung:
-11.11%
6M Leistung:
-43.01%
1J Leistung:
-12.20%
1-Tages-Spanne:
$2.03
$2.19
1-Wochen-Bereich:
$1.97
$2.19
52-Wochen-Spanne:
$1.90
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
Firmenname
Cardiff Oncology Inc
Sektor
Branche
Telefon
858-952-7570
Adresse
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Vergleichen Sie CRDF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
2.16 | 133.72M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-08 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2025-06-24 | Eingeleitet | Jefferies | Hold |
| 2024-09-06 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | William Blair | Outperform |
| 2021-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-08-09 | Fortgesetzt | Maxim Group | Buy |
| 2020-10-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-08 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Cardiff Oncology Inc Aktie (CRDF) Neueste Nachrichten
Published on: 2025-09-18 00:36:30 - newser.com
Can technical indicators confirm Cardiff Oncology Inc.’s reversalWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Cardiff Oncology Inc. stock momentum explainedQuarterly Profit Review & Consistent Profit Trading Strategies - newser.com
Published on: 2025-09-17 13:59:11 - خودرو بانک
Will Cardiff Oncology Inc. stock recover after recent dropJuly 2025 Action & Risk Controlled Swing Trade Alerts - newser.com
Jacobs Levy Equity Management Inc. Boosts Stock Position in Cardiff Oncology, Inc. $CRDF - MarketBeat
Will Cardiff Oncology Inc. continue its uptrendJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Activity Recap: Is Cardiff Oncology Inc a momentum stockTake Profit & Free Accurate Trade Setup Notifications - خودرو بانک
Aug Chart Watch: What dividend growth rate does Cardiff Oncology Inc offerQuarterly Profit Summary & Smart Swing Trading Alerts - خودرو بانک
Stock Analysis: How correlated is Cardiff Oncology Inc. to the S&P500Forecast Cut & AI Powered Buy and Sell Recommendations - خودرو بانک
Analyst Downgrade: What is Cardiff Oncology Inc. s 5 year growth outlook2025 Market WrapUp & Reliable Momentum Entry Alerts - خودرو بانک
Custom watchlist performance reports with Cardiff Oncology Inc.Quarterly Performance Summary & Fast Moving Trade Plans - newser.com
How to build a dashboard for Cardiff Oncology Inc. stockJuly 2025 Retail & Safe Capital Investment Plans - newser.com
Trend Recap: Does Cardiff Oncology Inc. offer margin of safetyBull Run & Weekly High Potential Alerts - خودرو بانک
Published on: 2025-09-16 04:00:25 - خودرو بانک
Market Moves: Can Cardiff Oncology Inc reach all time highs this yearTrend Reversal & Accurate Buy Signal Alerts - خودرو بانک
What momentum shifts mean for Cardiff Oncology Inc.Quarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - newser.com
Market Review: What is Cardiff Oncology Incs 5 year growth outlookFed Meeting & Community Trade Idea Sharing - خودرو بانک
Published on: 2025-09-15 12:44:30 - خودرو بانک
How institutional ownership impacts Cardiff Oncology Inc. stock2025 Valuation Update & Advanced Technical Analysis Signals - newser.com
Smart tools for monitoring Cardiff Oncology Inc.’s price actionMarket Sentiment Summary & Accurate Buy Signal Alerts - newser.com
Should you wait for a breakout in Cardiff Oncology Inc.July 2025 PreEarnings & Community Shared Stock Ideas - newser.com
Adage Capital Partners GP L.L.C. Has $4.54 Million Position in Cardiff Oncology, Inc. $CRDF - MarketBeat
Technical signs of recovery in Cardiff Oncology Inc.2025 Institutional Moves & Fast Exit and Entry Trade Guides - Newser
Cardiff Oncology, Inc. $CRDF Shares Purchased by MetLife Investment Management LLC - Defense World
Cardiff Oncology at H.C. Wainwright: Onvansertib’s Promising Path By Investing.com - Investing.com Canada
What moving averages say about Cardiff Oncology Inc.2025 Technical Overview & Safe Capital Growth Tips - Newser
Is Cardiff Oncology Inc. building a consolidation base2025 Big Picture & Real-Time Volume Surge Alerts - Newser
Will Cardiff Oncology Inc. rebound enough to break evenWeekly Market Outlook & Target Return Focused Stock Picks - Newser
Does Cardiff Oncology Inc. qualify in momentum factor screeningQuarterly Risk Review & Technical Entry and Exit Tips - Newser
Best data tools to analyze Cardiff Oncology Inc. stock2025 Trade Ideas & High Win Rate Trade Tips - Newser
Does Cardiff Oncology Inc. offer margin of safetyPortfolio Update Summary & Trade Opportunity Analysis Reports - خودرو بانک
Is Cardiff Oncology Inc. undervalued by DCF analysisPortfolio Risk Summary & Detailed Earnings Play Strategies - خودرو بانک
FOMO Trade: Will Cardiff Oncology Inc. benefit from sector rotationSell Signal & Reliable Trade Execution Plans - خودرو بانک
Is Cardiff Oncology Inc. trending in predictive chart modelsBond Market & Fast Entry and Exit Trade Plans - Newser
Is now a turning point for Cardiff Oncology Inc.Weekly Risk Report & Consistent Profit Alerts - Newser
Tick level data insight on Cardiff Oncology Inc. volatility2025 Macro Impact & Consistent Income Trade Ideas - Newser
Is Cardiff Oncology Inc. a momentum stockTrade Ideas & Technical Buy Zone Confirmations - 강소기업뉴스
Is Cardiff Oncology Inc. backed by strong institutional buyingMarket Growth Review & Advanced Swing Trade Entry Alerts - خودرو بانک
Will Cardiff Oncology Inc. price bounce be sustainableEarnings Recap Summary & High Conviction Buy Zone Alerts - Newser
Has Cardiff Oncology Inc. formed a bullish divergence2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
150,000 Shares in Cardiff Oncology, Inc. $CRDF Bought by DAFNA Capital Management LLC - MarketBeat
Will Cardiff Oncology Inc. benefit from rising consumer demandWeekly Gains Report & Expert-Curated Trade Recommendations - خودرو بانک
What high frequency data says about Cardiff Oncology Inc.Earnings Overview Report & Weekly Breakout Watchlists - Newser
What institutional flow reveals about Cardiff Oncology Inc.Weekly Investment Report & Safe Entry Point Identification - Newser
Should I average down on Cardiff Oncology Inc. stockDividend Hike & Trade Opportunity Analysis - خودرو بانک
What Fibonacci levels say about Cardiff Oncology Inc. reboundBreakout Watch & Verified High Yield Trade Plans - Newser
How moving averages guide Cardiff Oncology Inc. trading2025 Fundamental Recap & Precise Trade Entry Recommendations - Newser
Regression analysis insights on Cardiff Oncology Inc. performanceTrade Volume Summary & Daily Stock Trend Watchlist - Newser
Will a bounce in Cardiff Oncology Inc. offer an exitRisk Management & Daily Profit Maximizing Tips - Newser
Nuveen LLC Takes $2.69 Million Position in Cardiff Oncology, Inc. $CRDF - MarketBeat
Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cardiff Oncology Inc-Aktie (CRDF) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PACE GARY W | Director |
Jul 30 '25 |
Buy |
2.45 |
15,000 |
36,750 |
1,345,676 |
| Levine James E. | Chief Financial Officer |
Dec 17 '24 |
Buy |
5.42 |
2,752 |
14,905 |
65,316 |
| Levine James E. | Chief Financial Officer |
Dec 18 '24 |
Buy |
5.00 |
2,400 |
12,000 |
67,716 |
| Levine James E. | Chief Financial Officer |
Dec 16 '24 |
Buy |
3.83 |
2,564 |
9,820 |
62,564 |
| TANNENBAUM RENEE P | Director |
Dec 12 '24 |
Buy |
3.42 |
10,000 |
34,224 |
20,000 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
350,115 |
910,299 |
1,047,876 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
11,500 |
29,900 |
1,059,376 |
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):